Novel Targets for Treatment of Adult Acute Lymphocytic Leukemia

被引：0
|
作者：
Margaret T. Kasner
机构：
[1] Thomas Jefferson University,
来源：
Current Hematologic Malignancy Reports | 2010年 / 5卷
关键词：
Acute lymphocytic leukemia; Philadelphia+; Molecular targets; Tyrosine kinase inhibitors; Monoclonal antibodies; mTOR; Notch; CD19; CD20; CD22; CD52; Rapamycin; MEK;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The treatment of acute lymphocytic leukemia (ALL) results in long-term disease-free survival in only 30–40% of adults. Conventional chemotherapy is toxic and woefully ineffective. Therefore, novel agents are being investigated. Among these agents are monoclonal antibodies such as rituximab, epratuzumab, and alemtuzumab and targeted therapies such as tyrosine kinase inhibitors, mTOR inhibitors, and mitogen-activated protein kinase (MEK) inhibitors. This article discusses such novel targets for the treatment of ALL.
引用
收藏
页码：207 / 212
页数：5
相关论文
共 50 条
  • [21] Treatment of adult acute lymphoblastic leukemia with inotuzumab ozogamicin
    Paul, Shilpa
    Rausch, Caitlin R.
    Kantarjian, Hagop
    Jabbour, Elias J.
    FUTURE ONCOLOGY, 2017, 13 (25) : 2233 - 2242
  • [22] Mining the Microenvironment for Therapeutic Targets in Chronic Lymphocytic Leukemia
    Kipps, Thomas J.
    CANCER JOURNAL, 2021, 27 (04): : 306 - 313
  • [23] EPIDEMIOLOGY OF ACUTE LYMPHOCYTIC-LEUKEMIA
    ROY, P
    COLEMAN, MP
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 1992, 40 (05): : 323 - 334
  • [24] Novel targeted drug therapies I for the treatment of childhood acute leukemia
    Brown, Patrick
    Hunger, Steven P.
    Smith, Franklin O.
    Carroll, William L.
    Reaman, Gregory H.
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (02) : 145 - 158
  • [25] A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia
    Campbell, Laura K.
    Scaduto, Mary
    Sharp, William
    Dufton, Lynette
    Van Slyke, Deborah
    Whitlock, James A.
    Compas, Bruce
    PEDIATRIC BLOOD & CANCER, 2007, 49 (01) : 65 - 73
  • [26] Novel agents for chronic lymphocytic leukemia
    Wu, Mei
    Akinleye, Akintunde
    Zhu, Xiongpeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [27] Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications
    BS Dabaja
    S Faderl
    D Thomas
    J Cortes
    S O’Brien
    F Nasr
    S Pierce
    K Hayes
    A Glassman
    M Keating
    HM Kantarjian
    Leukemia, 1999, 13 : 869 - 872
  • [28] Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications
    Dabaja, BS
    Faderl, S
    Thomas, D
    Cortes, J
    O'Brien, S
    Nasr, F
    Pierce, S
    Hayes, K
    Glassman, A
    Keating, M
    Kantarjian, HM
    LEUKEMIA, 1999, 13 (06) : 869 - 872
  • [29] Phase II study of single agent paclitaxel in adult patients with relapsed acute lymphocytic leukemia
    Colburn, DE
    Thomas, DA
    Giles, FJ
    INVESTIGATIONAL NEW DRUGS, 2003, 21 (01) : 109 - 111
  • [30] Phase II Study of Single Agent Paclitaxel in Adult Patients with Relapsed Acute Lymphocytic Leukemia
    Dawn E. Colburn
    Deborah A. Thomas
    Francis J. Giles
    Investigational New Drugs, 2003, 21 : 109 - 111
12345